These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34668921)

  • 1. Physician Perspectives on the Effect of Topical Steroid Costs on Patients and Proposed Solutions.
    Kassamali B; Faletsky A; Han JJ; Lee K; Lopez C; Lee MS; Pérez-Chada LM; Mostaghimi A; Lachance A
    JAMA Dermatol; 2022 Jan; 158(1):79-83. PubMed ID: 34668921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H; Adamson A; Mostaghimi A
    JAMA Dermatol; 2017 Aug; 153(8):755-759. PubMed ID: 28453645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling.
    Sloan CE; Millo L; Gutterman S; Ubel PA
    JAMA Netw Open; 2021 Nov; 4(11):e2133188. PubMed ID: 34739059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information system technologies' role in augmenting dermatologists' knowledge of prescription medication costs.
    DeMarco SS; Paul R; Kilpatrick RJ
    Int J Med Inform; 2015 Dec; 84(12):1076-84. PubMed ID: 26228652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. U.S. Internists' Perspectives on Discussing Cost of Care With Patients: Structured Interviews and a Survey.
    Perez SL; Weissman A; Read S; Smith CD; Colello L; Peter D; Nickel W
    Ann Intern Med; 2019 May; 170(9_Suppl):S39-S45. PubMed ID: 31060057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Real-time Prescription Benefit Recommendations on Patient Out-of-Pocket Costs: A Cluster Randomized Clinical Trial.
    Desai SM; Chen AZ; Wang J; Chung WY; Stadelman J; Mahoney C; Szerencsy A; Anzisi L; Mehrotra A; Horwitz LI
    JAMA Intern Med; 2022 Nov; 182(11):1129-1137. PubMed ID: 36094537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states.
    Khan S; Sylvester R; Scott D; Pitts B
    J Manag Care Pharm; 2008 Oct; 14(8):780-9. PubMed ID: 18983207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K; Dusetzina SB; Basu A
    JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of antidepressant prescribing concentration to treatment duration and cost.
    Hodgkin D; Merrick EL; Hiatt D
    J Ment Health Policy Econ; 2012 Mar; 15(1):3-11. PubMed ID: 22611088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' attitudes about prescribing and knowledge of the costs of common medications.
    Reichert S; Simon T; Halm EA
    Arch Intern Med; 2000 Oct; 160(18):2799-803. PubMed ID: 11025790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-physician communication about out-of-pocket costs.
    Alexander GC; Casalino LP; Meltzer DO
    JAMA; 2003 Aug; 290(7):953-8. PubMed ID: 12928475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating E-Prescribing and Pharmacy Claims Data for Predictive Modeling: Comparing Costs and Utilization of Health Plan Members Who Fill Their Initial Medications with Those Who Do Not.
    Chang HY; Kan HJ; Shermock KM; Alexander GC; Weiner JP; Kharrazi H
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1282-1290. PubMed ID: 32996394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?
    Shrank WH; Joseph GJ; Choudhry NK; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL
    Am J Manag Care; 2006 Sep; 12(9):545-51. PubMed ID: 16961443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.
    Tamblyn R; Winslade N; Qian CJ; Moraga T; Huang A
    Implement Sci; 2018 Jan; 13(1):7. PubMed ID: 29321043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.
    Zafar S; Wang P; Schein OD; Srikumaran D; Makary M; Woreta FA
    Ophthalmology; 2020 May; 127(5):573-581. PubMed ID: 31952884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pharmacy benefit design on patient-physician communication about costs.
    Shrank WH; Fox SA; Kirk A; Ettner SL; Cantrell CH; Glassman P; Asch SM
    J Gen Intern Med; 2006 Apr; 21(4):334-9. PubMed ID: 16686808
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.